DOCSLIB.ORG

A Bone Marrow Niche-Derived Molecular Switch Between Osteogenesis and Hematopoiesis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Bone Marrow Niche-Derived Molecular Switch Between Osteogenesis and Hematopoiesis Downloaded from genesdev.cshlp.org on October 5, 2021 - Published by Cold Spring Harbor Laboratory Press OUTLOOK A bone marrow niche-derived molecular switch between osteogenesis and hematopoiesis Marta Galán-Díez and Stavroula Kousteni Department of Physiology and Cellular Biophysics, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA Hematopoietic stem cells (HSCs) reside and are main- tions of HSCs such as homing, mobilization, quiescence, tained in specialized microenvironments within the self-renewal, or lineage commitment. Instructive cues are bone marrow known as niches, which are comprised of provided as essential autocrine, endocrine, and paracrine various cell types. Among them, leptin receptor (LepR)-ex- signals as well as direct cell–cell interactions between pressing CXC chemokine ligand 12 (CXCL12)-abundant the stromal niches and the HSCs. reticular (CAR) cells are known to create a niche for Numerous studies have examined the role of the osteo- HSCs and at the same time to give rise to osteoblasts. blast lineage in HSCs and point toward the notion that os- These two functions of CAR/LepR+ cells appear to be teoblast regulation of hematopoiesis depends on the stage tightly but inversely regulated to ensure adequate physical of osteoblast differentiation (Sacchetti et al. 2007; Wu space for HSCs. However, how osteogenesis is prevented et al. 2008; Méndez-Ferrer et al. 2010; Calvi et al. 2012; in CAR cells to maintain spaces available for HSCs and he- Kunisaki et al. 2013). Whereas the most immature un- matopoiesis remains unclear. In this issue of Genes & De- committed progenitor subset influences HSC mainte- velopment, Seike and colleagues (pp. 359–372) report that nance and proliferation, committed progenitors or the transcription factor early B-cell factor (Ebf3) is prefer- mature osteoblasts tailor HSC differentiation along the entially expressed by CAR/LepR+ cells and inhibits CAR lymphoid, myeloid, and erythroid lineages (Calvi et al. cell differentiation into osteoblasts while at the same 2003; Zhu et al. 2007; Ding and Morrison 2013; Krevvata time maintaining self-renewal of CAR/LepR+ cells. Using et al. 2014). Indeed, self-renewing osteoprogenitor cells in conditional knockout and retroviral systems, the investi- the marrow can form supportive HSC niches (Sacchetti gators show that loss of Ebf3 in CAR cells impairs HSC et al. 2007). Mesenchymal stem cells (MSCs) of the endos- numbers and leads to osteosclerosis. This study provides teal niche in closest proximity to HSCs express secreted or novel insights into transcriptional requirements for CAR cell surface molecules that regulate HSC quiescence cell bone formation by identifying Ebf3 as a niche factor se- (Nilsson et al. 2005; Silberstein et al. 2016). Nestin-posi- creted from CAR/Lepr+ cells that regulates the interplay tive MSCs produce soluble factors involved in HSC main- between osteogenesis and hematopoiesis. tenance, such as CXC chemokine ligand 12 (CXCL12) and stem cell factor (SCF), and colocalize with HSCs, and their depletion results in HSC mobilization (Méndez-Ferrer One of the critical and unique functions of the skeleton is et al. 2010). These observations suggested that osteogene- to provide the anatomical spaces for maintaining hemato- sis and HSC maintenance in the marrow may be inversely poiesis. Bone marrow is the main site of residence for he- related. matopoietic stem cells (HSCs), where they self-renew, Perivascular niches regulate HSC maintenance and qui- + proliferate, or become progressively restricted to several escence. An arteriolar niche marked by rare NG2 (CSPG4 ) committed precursors and/or single lineages that give pericytes inhibits HSC cycling and reduces functional rise to the different types of mature blood cells. In the long-term repopulating HSCs in the bone marrow (Kuni- bone marrow, HSCs interact dynamically with an intri- saki et al. 2013). A distinct perisinusoid niche containing cate network of stromal cells. Such groups of cells com- the majority of dividing and nondividing HSCs appears prise a collection of several specialized “microniches” to regulate the interplay between osteogenesis and hema- that sustain hematopoiesis by influencing different func- topoiesis. Cells within the perisinusoid niche that express © 2018 Galán-Díez and Kousteni This article is distributed exclusively [Keywords: Ebf3; stem cell niche; hematopoietic stem cell; mesenchymal by Cold Spring Harbor Laboratory Press for the first six months after the stem cell; bone] full-issue publication date (see http://genesdev.cshlp.org/site/misc/ Corresponding author: [email protected] terms.xhtml). After six months, it is available under a Creative Commons Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.314013. License (Attribution-NonCommercial 4.0 International), as described at 118. http://creativecommons.org/licenses/by-nc/4.0/. 324 GENES & DEVELOPMENT 32:324–326 Published by Cold Spring Harbor Laboratory Press; ISSN 0890-9369/18; www.genesdev.org Downloaded from genesdev.cshlp.org on October 5, 2021 - Published by Cold Spring Harbor Laboratory Press A bone marrow niche-derived molecular switch high levels of CXCL12 and SCF (CXCL12-abundant retic- of age, double-knockout mice showed an occlusion of the ular [CAR] cells) make up the majority of perivascular cells marrow cavity and reduced CAR cell number. Therefore, (Omatsu et al. 2010) and overlap with perisinusoidal cells, Ebf1/Ebf3 do not appear to define CAR cell fate during identified on the basis of their expression of the leptin re- embryogenesis but are required to inhibit differentiation ceptor (LepR) (Zhou et al. 2014). CAR and CAR/LepR+ of CAR cells into the osteoblast lineage to maintain the MSCs, representing ∼0.3% of bone marrow cells, include marrow spaces. nearly all of the colony-forming unit fibroblasts (CFU- To investigate the respective contributions of Ebf3 and Fs), are the major source of adipocytes and osteoblasts in Ebf1 in HSC maintenance and osteoblast differentiation, adult mouse bone marrow, and are required to support the investigators studied the skeletal and hematopoietic HSC maintenance. However, the majority of CAR/LepR+ phenotypes of adult CAR/LepR+ cell-specific Ebf1−/−; cells might remain undifferentiated in the bone marrow Ebf3+/− and Ebf1−/+;Ebf3−/− mice. A severe reduction of cavity, and it remains unclear how osteogenesis is prevent- HSC progenitors in the marrow resulted in extramedullary ed in most CAR/LepR+ cells to maintain the spaces avail- hematopoiesis and a marked increase in trabecular bone able for HSCs and hematopoiesis. mass. This was due to increased osteoblast numbers with- To address this question, Seike et al. (2018) sought to out changes in osteoclasts, which was observed in Ebf1−/+; identify transcriptional regulators of CAR cells and fo- Ebf3−/− mice but not in Ebf1−/−;Ebf3+/− mice at 34 wk of cused on transcription factors of the early B-cell factor age. CAR cells from CAR/LepR+ cell-specific Ebf1−/+; (Ebf) family. They found that Ebf3 is preferentially ex- Ebf3−/− mice, but not Ebf1−/−;Ebf3+/− mice, had higher ex- pressed in CAR cells, as compared with endothelial, he- pression of osteoblast markers. Therefore, the activity of matopoietic, and stromal cells of adult marrow. Lineage one functional Ebf3 allele is sufficient to maintain marrow tracing of Ebf3-expressing CAR/LepR+ cells was per- spaces and HSCs and suppress osteoblastogenesis, where- formed using triple-mutant mice expressing CreERT2 as one Ebf1 allele is not. Finally, overexpression of Ebf1 knocked into the endogenous Ebf3 locus, the Cxcl12- and Ebf3 in sorted CAR cells increased expression of GFP transgene, and Cre-activated Rosa26 tandem dimer Cxcl12 and Scf and decreased their osteogenic potential Tomato (tdTomato). The number of Ebf3-expressing in culture. This effect was dependent on the DNA-binding CAR cells, which give rise to adipocytes and osteoblasts domain of Ebf3. in the bone marrow, remained stable over the course of In conclusion, this study identifies Ebf3 as the molecu- 13 mo, suggesting that they have the capacity to self-re- lar trigger that acts in both a cell-autonomous and a cell- new. Conditional deletion of Ebf3 in CAR/LepR+ cells or nonautonomous manner in CAR/LepR+ cells—to sup- in all MSCs of developing limbs resulted in decreased press their differentiation to the osteoblast lineage so as numbers of long-term repopulating HSCs (LT-HSCs), to maintain their HSC-supporting function (Fig. 1). The megakaryocyte/erythrocyte progenitors (MEPs) proery- precise characteristics of the osteolineage cells responsi- throblasts, common lymphoid progenitors (CLPs), and ble for HSC support are of great interest, since they could granulocyte/macrophage progenitors (GMPs). Moreover, be used to predict whether therapeutic strategies that reg- in aged mice, the number of functional HSCs decreased. ulate osteoblastic commitment could also be exploited to This compromised hematopoietic phenotype correlated enhance the formation of HSC niches from nonniche with increased osteoblast numbers and osteogenesis and cells. lower expression of Cxcl12 and Scf in CAR/LepR+ cells. As a result, aged mice became osteosclerotic. Interesting- ly, residual platelet-derived growth factor receptor β-posi- tive (PDGFRβ+)Sca-1−CD31−CD45− and Ter119− CAR References cells had much higher expression levels of osteoblast Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, markers. Collectively, these results showed
Load more

Recommended publications
  • Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease Bone Marrow (Stem Cell) Transplant
    Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease 1 Produced by St. Jude Children’s Research Hospital Departments of Hematology, Patient Education, and Biomedical Communications. Funds were provided by St. Jude Children’s Research Hospital, ALSAC, and a grant from the Plough Foundation. This document is not intended to take the place of the care and attention of your personal physician. Our goal is to promote active participation in your care and treatment by providing information and education. Questions about individual health concerns or specifi c treatment options should be discussed with your physician. For more general information on sickle cell disease, please visit our Web site at www.stjude.org/sicklecell. Copyright © 2009 St. Jude Children’s Research Hospital How did bone marrow (stem cell) transplants begin for children with sickle cell disease? Bone marrow (stem cell) transplants have been used for the treatment and cure of a variety of cancers, immune system diseases, and blood diseases for many years. Doctors in the United States and other countries have developed studies to treat children who have severe sickle cell disease with bone marrow (stem cell) transplants. How does a bone marrow (stem cell) transplant work? 2 In a person with sickle cell disease, the bone marrow produces red blood cells that contain hemoglobin S. This leads to the complications of sickle cell disease. • To prepare for a bone marrow (stem cell) transplant, strong medicines, called chemotherapy, are used to weaken or destroy the patient’s own bone marrow, stem cells, and infection fi ghting system.
    [Show full text]
  • Adaptive Immune Systems
    Immunology 101 (for the Non-Immunologist) Abhinav Deol, MD Assistant Professor of Oncology Wayne State University/ Karmanos Cancer Institute, Detroit MI Presentation originally prepared and presented by Stephen Shiao MD, PhD Department of Radiation Oncology Cedars-Sinai Medical Center Disclosures Bristol-Myers Squibb – Contracted Research What is the immune system? A network of proteins, cells, tissues and organs all coordinated for one purpose: to defend one organism from another It is an infinitely adaptable system to combat the complex and endless variety of pathogens it must address Outline Structure of the immune system Anatomy of an immune response Role of the immune system in disease: infection, cancer and autoimmunity Organs of the Immune System Major organs of the immune system 1. Bone marrow – production of immune cells 2. Thymus – education of immune cells 3. Lymph Nodes – where an immune response is produced 4. Spleen – dual role for immune responses (especially antibody production) and cell recycling Origins of the Immune System B-Cell B-Cell Self-Renewing Common Progenitor Natural Killer Lymphoid Cell Progenitor Thymic T-Cell Selection Hematopoetic T-Cell Stem Cell Progenitor Dendritic Cell Myeloid Progenitor Granulocyte/M Macrophage onocyte Progenitor The Immune Response: The Art of War “Know your enemy and know yourself and you can fight a hundred battles without disaster.” -Sun Tzu, The Art of War Immunity: Two Systems and Their Key Players Adaptive Immunity Innate Immunity Dendritic cells (DC) B cells Phagocytes (Macrophages, Neutrophils) Natural Killer (NK) Cells T cells Dendritic Cells: “Commanders-in-Chief” • Function: Serve as the gateway between the innate and adaptive immune systems.
    [Show full text]
  • Bone Marrow Biopsy
    Helpline (freephone) 0808 808 5555 [email protected] www.lymphoma-action.org.uk Bone marrow biopsy This information is about a test called a bone marrow biopsy. You might have one to check if you have lymphoma in your bone marrow. On this page What is bone marrow? What is a bone marrow biopsy? Who might need one? Having a bone marrow biopsy Is a bone marrow biopsy safe? Getting the results We have separate information about the topics in bold font. Please get in touch if you’d like to request copies or if you would like further information about any aspect of lymphoma. Phone 0808 808 5555 or email [email protected]. What is bone marrow? Bone marrow is the spongy tissue in the middle of some of the bigger bones in your body, such as your thigh bone (femur), breastbone (sternum), hip bone (pelvis) and back bones (vertebrae). Your bone marrow is where blood cells are made. It contains cells called blood (‘haemopoietic’) stem cells. Stem cells are undeveloped cells that can divide and grow into all the blood cells you need. This includes red blood cells, platelets and all the different types of white blood cells. Page 1 of 8 © Lymphoma Action Figure: The different blood cells that develop in the bone marrow What is a bone marrow biopsy? A bone marrow biopsy is a test that involves taking a sample of bone marrow to be examined under a microscope. The samples are sent to a lab where an expert examines them.
    [Show full text]
  • Terminology Resource File
    Terminology Resource File Version 2 July 2012 1 Terminology Resource File This resource file has been compiled and designed by the Northern Assistant Transfusion Practitioner group which was formed in 2008 and who later identified the need for such a file. This resource file is aimed at Assistant Transfusion Practitioners to help them understand the medical terminology and its relevance which they may encounter in the patient’s medical and nursing notes. The resource file will not include all medical complaints or illnesses but will incorporate those which will need to be considered and appreciated if a blood component was to be administered. The authors have taken great care to ensure that the information contained in this document is accurate and up to date. Authors: Jackie Cawthray Carron Fogg Julia Llewellyn Gillian McAnaney Lorna Panter Marsha Whittam Edited by: Denise Watson Document administrator: Janice Robertson ACKNOWLEDGMENTS We would like to acknowledge the following people for providing their valuable feedback on this first edition: Tony Davies Transfusion Liaison Practitioner Rose Gill Transfusion Practitioner Marie Green Transfusion Practitioner Tina Ivel Transfusion Practitioner Terry Perry Transfusion Specialist Janet Ryan Transfusion Practitioner Dr. Hazel Tinegate Consultant Haematologist Reviewed July 2012 Next review due July 2013 Version 2 July 2012 2 Contents Page no. Abbreviation list 6 Abdominal Aortic Aneurysm (AAA) 7 Acidosis 7 Activated Partial Thromboplastin Time (APTT) 7 Acquired Immune Deficiency Syndrome
    [Show full text]
  • The Bridge Between Bone Marrow Adipocytes and Hematopoietic Cells Ziru Li and Ormond A
    EDITORIALS Stem cell factor: the bridge between bone marrow adipocytes and hematopoietic cells Ziru Li and Ormond A. MacDougald Department of Molecular & Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI, USA. E-mail: ZIRU LI - [email protected] doi:10.3324/haematol.2019.224188 hite adipocytes serve as an energy reservoir to in the bone marrow supernatant, which indicates that store excessive calories in the form of lipid BMAT is a primary source of SCF in bone marrow.5 Wdroplets and protect other tissues or organs from Deficiency of SCF in BMAT reduces the bone marrow cellu- ectopic lipid accumulation. Brown adipocytes express larity, hematopoietic stem and progenitor cells (HSPC), com- uncoupling protein 1 and are integral to adaptive thermoge- mon myeloid progenitors (CMP), megakaryocyte-erythro- nesis. Whereas the functions of adipocytes in either white or cyte progenitor (MEP) and granulocyte-monocyte progeni- brown adipose tissues are well documented, our knowledge tors (GMP) under steady-state condition. Consistent with of bone marrow adipocytes (BMA) remains in its infancy. these changes in the progenitor cells of bone marrow, mice Bone marrow adipose tissue (BMAT) occupies approximate- deficient for adipocyte SCF develop macrocytic anemia and ly 50-70% of the bone marrow volume in human adults.1 It reduction of neutrophils, monocytes and lymphocytes in cir- is a dynamic tissue and responds to multiple metabolic con- culation. In contrast to results in this study, Zhou et al. ditions. For example, BMAT
    [Show full text]
  • Nomina Histologica Veterinaria, First Edition
    NOMINA HISTOLOGICA VETERINARIA Submitted by the International Committee on Veterinary Histological Nomenclature (ICVHN) to the World Association of Veterinary Anatomists Published on the website of the World Association of Veterinary Anatomists www.wava-amav.org 2017 CONTENTS Introduction i Principles of term construction in N.H.V. iii Cytologia – Cytology 1 Textus epithelialis – Epithelial tissue 10 Textus connectivus – Connective tissue 13 Sanguis et Lympha – Blood and Lymph 17 Textus muscularis – Muscle tissue 19 Textus nervosus – Nerve tissue 20 Splanchnologia – Viscera 23 Systema digestorium – Digestive system 24 Systema respiratorium – Respiratory system 32 Systema urinarium – Urinary system 35 Organa genitalia masculina – Male genital system 38 Organa genitalia feminina – Female genital system 42 Systema endocrinum – Endocrine system 45 Systema cardiovasculare et lymphaticum [Angiologia] – Cardiovascular and lymphatic system 47 Systema nervosum – Nervous system 52 Receptores sensorii et Organa sensuum – Sensory receptors and Sense organs 58 Integumentum – Integument 64 INTRODUCTION The preparations leading to the publication of the present first edition of the Nomina Histologica Veterinaria has a long history spanning more than 50 years. Under the auspices of the World Association of Veterinary Anatomists (W.A.V.A.), the International Committee on Veterinary Anatomical Nomenclature (I.C.V.A.N.) appointed in Giessen, 1965, a Subcommittee on Histology and Embryology which started a working relation with the Subcommittee on Histology of the former International Anatomical Nomenclature Committee. In Mexico City, 1971, this Subcommittee presented a document entitled Nomina Histologica Veterinaria: A Working Draft as a basis for the continued work of the newly-appointed Subcommittee on Histological Nomenclature. This resulted in the editing of the Nomina Histologica Veterinaria: A Working Draft II (Toulouse, 1974), followed by preparations for publication of a Nomina Histologica Veterinaria.
    [Show full text]
  • B-Cell Development, Activation, and Differentiation
    B-Cell Development, Activation, and Differentiation Sarah Holstein, MD, PhD Nov 13, 2014 Lymphoid tissues • Primary – Bone marrow – Thymus • Secondary – Lymph nodes – Spleen – Tonsils – Lymphoid tissue within GI and respiratory tracts Overview of B cell development • B cells are generated in the bone marrow • Takes 1-2 weeks to develop from hematopoietic stem cells to mature B cells • Sequence of expression of cell surface receptor and adhesion molecules which allows for differentiation of B cells, proliferation at various stages, and movement within the bone marrow microenvironment • Immature B cell leaves the bone marrow and undergoes further differentiation • Immune system must create a repertoire of receptors capable of recognizing a large array of antigens while at the same time eliminating self-reactive B cells Overview of B cell development • Early B cell development constitutes the steps that lead to B cell commitment and expression of surface immunoglobulin, production of mature B cells • Mature B cells leave the bone marrow and migrate to secondary lymphoid tissues • B cells then interact with exogenous antigen and/or T helper cells = antigen- dependent phase Overview of B cells Hematopoiesis • Hematopoietic stem cells (HSCs) source of all blood cells • Blood-forming cells first found in the yolk sac (primarily primitive rbc production) • HSCs arise in distal aorta ~3-4 weeks • HSCs migrate to the liver (primary site of hematopoiesis after 6 wks gestation) • Bone marrow hematopoiesis starts ~5 months of gestation Role of bone
    [Show full text]
  • Hematopoiesis in the Bone Marrow FADD Deficiency Impairs Early
    FADD Deficiency Impairs Early Hematopoiesis in the Bone Marrow Stephen Rosenberg, Haibing Zhang and Jianke Zhang This information is current as J Immunol 2011; 186:203-213; Prepublished online 29 of September 27, 2021. November 2010; doi: 10.4049/jimmunol.1000648 http://www.jimmunol.org/content/186/1/203 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2010/11/29/jimmunol.100064 Material 8.DC1 References This article cites 77 articles, 37 of which you can access for free at: http://www.jimmunol.org/content/186/1/203.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 27, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology FADD Deficiency Impairs Early Hematopoiesis in the Bone Marrow Stephen Rosenberg, Haibing Zhang, and Jianke Zhang Signal transduction mediated by Fas-associated death domain protein (FADD) represents a paradigm of coregulation of apoptosis and cellular proliferation. During apoptotic signaling induced by death receptors including Fas, FADD is required for the recruit- ment and activation of caspase 8.
    [Show full text]
  • Glossary of Medical Terms
    Glossary of Medical Terms A Absolute Neutrophil Count (ANC): The real number of white blood cells (WBCs) that are neutrophils. Neutrophils are key components in the system of defense against infection. Having few neutrophils present is called neutropenia. Acyclovir: An anti-viral drug used to treat or prevent cytomegalovirus and herpes simplex infections. Adenovirus: A set of viruses that induce respiratory tract and eye infections. Gene therapy uses adenoviruses that are modified to carry a particular tumor-fighting gene. Adrenal glands: Glands located on top of each kidney that secretes several important hormones into the blood. The inner portion of the adrenal gland, the adrenal medulla, stores and releases catecholamines that are measured by testing urine samples. Alkylating Agents: A class of anticancer drugs that interferes with the cell's DNA and restrains or halts cancer cell growth. Allogeneic: (Bone Marrow or Peripheral Blood Stem Cell Transplant) a transplant using bone marrow or stem cells from a matched sibling donor infused into recipient after high dose chemotherapy. Angiogenesis: Blood vessel formation. Angiogenesis involves the growth of blood vessels from surrounding tissue into a solid tumor. Antiangiogenesis drugs are drugs that prevent the growth of new blood vessels into a solid tumor. Anthracyclines: A class of antibiotics used in many induction chemotherapy regimens for high-risk neuroblastoma. It is important to keep track of the cumulative dose of anthracyclines a child receives because these drugs can damage the heart muscle. Antibiotics: Drugs used to fight bacterial infections. Antibody: A substance made by the immune system, used to defend the body against bacteria, viruses, toxins or tumors.
    [Show full text]
  • Two Branches of Immune System
    Two branches of immune system Innate Adaptive Characteristics of innate immunity –Act the same way in all individuals –Requires no previous exposure to pathogen –Seen in many types of animals –Available early in infection –Necessary for induction of adaptive immunity Characteristics of adaptive immunity – Specific to a given pathogen – Occurs within lifetime of the individual – Only in vertebrates – Takes time to mount specific response later in infection (4-5 days) Innate defenses • Barriers • Phagocytosis and inflammation • Complement • Natural killer cells Barriers • Mechanical/Physical • Chemical • Microbiological Phagocytosis Neutrophil Macrophage Inflammation Complement activation Adaptive Innate Fig. 2.18 Adaptive responses • Antibody production (B cells) • Cell mediated response (T cells) – Cytotoxic T cells= kill infected cells – Helper T cells= increase activity of other cells of the immune system (Macrophages, B cells) • Potentiate the function of accessory cells: – NK cells – Macrophages/neutrophils – Eosinophils – Basophils – Mast cells Adaptive responses are specific to antigen • Antigen= – Recognized as foreign= “non-self” – Generally protein – Can be carbohydrate or nucleic acid – Only portion of a protein recognized by receptor= epitope – Recognized by Ig of B cells or TCR of T cells Immunoglobulin= Antibody T cell receptor (TCR): recognizes Ag bound in cleft of MHC Questions • Where do cells of the immune system come from? • How is diversity in Ag receptors (Ig or TCR) accomplished? • How are lymphocytes activated in
    [Show full text]
  • Bone Marrow Biopsy
    BONE MARROW BIOPSY Appointment Date: ____________________________ Time______________________ LOCATION: Aultman Main Hospital: 2600 6th St. SW, Canton DEPARTMENT: Aultman Endoscopy/Minor Surgery Department on Main 2 SUMMARY OF THE EXAM: A bone marrow biopsy is a procedure done to remove a small amount of marrow from your bone. Bone marrow is the soft, spongy tissue inside of your larger bones that makes blood cells. The procedure lasts approximately 15 minutes. INSTRUCTIONS One week before your procedure Check with your doctor for specific instructions if you are taking aspirin, anti- inflammatory drugs, insulin, or anticoagulants (blood thinners) Make sure you have arrangements to have someone with you who can drive you home after your procedure. The evening before your procedure Do not eat or drink ANYTHING after midnight, unless otherwise instructed by your doctor. The day of your procedure Bring a complete list of all your medications including prescription and over-the counter medications, herbal supplements, and vitamins. Wear loose fitting clothes that will be comfortable for you to wear home. Leave valuables such as cash, credit cards or jewelry at home. Report to the Endoscopy/Minor Surgery Department at least one hour before your scheduled procedure time. You will be asked to sign a consent form to allow the doctor to perform the procedure. You will be escorted to the prep/recovery area, where you will change into a gown. Lockers are provided. Your family member/friend may wait for you in the waiting room. The nurse will start an intravenous (IV) line to provide fluids and sedation During your procedure You will lie on your side on a cart with your knees pulled up to your stomach Medicine will be given through your IV line to relax you and keep you comfortable.
    [Show full text]
  • Understanding the Immune System and Lymphoma
    Understanding the Immune System and Lymphoma The body’s immune system is comprised of a network of cells, tissues, and organs. This network operates together to eliminate harmful pathogens, like bacteria and viruses, as well as cancer cells from the body. The immune system provides two different types of immunity: • Innate (meaning “inborn” or “natural”) immunity — This type of immunity is provided by natural barriers in the body, substances in the blood, and specific cells that attack and kill foreign cells. Examples of natural barriers include skin,mucous membranes, stomach acid, and the cough reflex. These barriers keep germs (bacteria or viruses) and other harmful substances from entering the body. Inflammation (redness and swelling) is also a type of innate immunity. Blood cells that are part of the innate immune system include neutrophils, macrophages, eosinophils, and basophils. • Adaptive (meaning adapting to external forces or threats) immunity — This type of immunity is provided by the thymus gland, spleen, tonsils, bone marrow, circulatory system, and lymphatic system. B cells and T cells, the two main types of lymphocytes, carry out the adaptive immune response by recognizing and either inactivating or killing specific invading organisms. The adaptive immune system can then “remember” the identity of the invader, so that the next time the body is infected by the same invader, the immune response will develop more quickly and strongly. All normal cells have a limited lifespan. A self-destruct mechanism called apoptosis is triggered when cells become senescent (too old) or get damaged; this natural process is called apoptosis or programmed sequence of events that lead to the cell’s death.
    [Show full text]